Fluoroestradiol PET Imaging in Predicting Response to Hormone Therapy of Breast Cancer

Summary

Compare the response rate after 6 months of hormone treatment (or a major change in hormone treatment) in metastatic breast cancer, according to the uptake of FES in metastatic lesions taking-up FDG on PET/CT at baseline. Hypothesis: best response rate will be observed in patients with all metastases taking up FES prior to treatment.

Timeline

Start

2012-06

Primary completion

2015-01

Completion

2015-01

Drugs

Indications